NOBEL BIOCARE DANMARK A/S: Financial statements 2012
CVR: 28293364
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
NOBEL BIOCARE DANMARK A/S (CVR 28293364) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 6,081,398 and a net result of DKK 408,697. Equity in the 2012 report amounted to DKK 4,654,877. The solvency ratio was 54.7%.
- Gross Profit
- DKK 6,081,398
- Profit/Loss
- DKK 408,697
- Equity
- DKK 4,654,877
- Total Assets
- DKK 8,505,939
Official annual report
Keep an eye on NOBEL BIOCARE DANMARK A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of April 17, 2012, Karl Magnus Persson has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of April 17, 2012, Alexander Johannes Ochsner has left the board of directors of NOBEL BIOCARE DANMARK A/S.
About NOBEL BIOCARE DANMARK A/S
NOBEL BIOCARE DANMARK A/S is a Danish company of the type Aktieselskab based in Silkeborg, founded in 2004. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Jan Jerne. The board consists of Magnus Karl Andreas Pettersson (chair), Harrieth Eva Elisabeth Sundaeus and Jan Jerne. The company is owned by Nobel Biocare AB. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,044,322 and a net result of DKK -4,810,707 compared with DKK -4,496,854 the year before. Equity in the 2025 report amounted to DKK -10,951,798.